Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Management and Research Année : 2021

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib

Domaines

Cancer

Dates et versions

hal-04504259 , version 1 (14-03-2024)

Identifiants

Citer

Francesco Facchinetti, Antonin Levy, Samy Ammari, Charles Naltet, Pernelle Lavaud, et al.. Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib. Cancer Management and Research, 2021, Volume 13, pp.2805-2810. ⟨10.2147/CMAR.S292730⟩. ⟨hal-04504259⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More